Dec 7, 2019
See more photo highlights from...
Dec 7, 2019
Ayesha N. Zia, MD ASH News Daily Editor-in-Chief The Hebrew word for it is hrh. The Hindus speak of prabodhan. In Chinese, it’s qishi. The teachings of Buddhism discuss bodhi … keihatsu in Japanese. The French use eclaircissement. In my native language, Urdu, it...
Dec 7, 2019
By Ilana Yurkiewicz, MD My first question was critical: What kind of gifts will ASH-a-Palooza bear this year? Formerly known as “Trainee Day,” the now reinvented ASH-a-Palooza was a half-day, interactive tour de force of learning, networking, and mentorship. There...
Dec 7, 2019
By Binod Dhakal, MD, MS The year 1982 heralds the discovery of the first mutated genes to be identified in cancer, RAS. The three RAS genes — KRAS, NRAS, and HRAS — still constitute the most frequently mutated oncogene family in human cancers. However, despite more...
Dec 7, 2019
By Janice Staber, MD Since I was little, I’ve been surrounded by scientific intrigue. One of my first memories of the idea of moving genetic material into a person was from my early high school days. When discussing gene transfer, a classmate asked, “So, we could make...
Dec 7, 2019
Continuing Conversations With the Speakers sessions allow for informal discussions with Scientific Program session speakers that will give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic...
Dec 7, 2019
By Lynn Malec, MD, MSc, and Janice Staber, MD Your patient with a new blood clot doesn’t want to give herself shots, and the prospect of frequent lab work is going to be a deal-breaker. A direct oral anticoagulant (DOAC) seems like an obvious choice. But what if the...
Dec 7, 2019
By Binod Dhakal, MD, MS More than a century ago, the brilliant physicist Max Planck investigated an obscure subject and sparked a revolution in physics. A profoundly conservative thinker, Planck had to disavow some orthodox theoretical ideas to assume that the total...
Dec 7, 2019
By Basem M. William, MD We have made significant progress in our understanding of the pathogenesis and progression of lymphoma through the molecular dissection of malignant cells. By contrast, the importance of the cellular context in which these malignant cells arise...
Dec 7, 2019
After the uniquely positive experiences following the launch of the initial local language editions of Blood in Italy, Spain, and Latin America, we are delighted to announce that two new editions are being added to the international family of journals: Chinese Blood...
Dec 7, 2019
By Basem M. William, MD Since Thomas Hodgkin’s initial characterization of lymphomas in 1832 and the first administration of mustard to a patient with lymphoma 100 years later amid the secrecy of a World War II gas program, much has changed. Multiple recurrent themes...
Dec 7, 2019
By Alexander K. Glaros, MD, and Ahmar U. Zaidi, MD In the social media community of patients with sickle cell disease (SCD) and their advocates, the moniker of “sickle cell warrior” has been widely adopted to unify those who struggle daily with the burden of this...
Dec 7, 2019
...
Dec 5, 2019
The Global Capacity-Building Showcase (Hall B, Level 2 [Orange County Convention Center] – map it ) is an annual meeting poster category designed to encourage international collaborations in the form of capacity-building programs in low- and middle-income...
Dec 5, 2019
Applying the principles of precision medicine to hematologic diseases is a priority for ASH. Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of...
Dec 5, 2019
This year’s meeting will offer two Special-Interest Sessions tailored for all those who have an interest in learning more about both sides of the peer review process. First Editor-in-Chief of Blood Bob Löwenberg, MD, PhD, will lead the discussion “How to Get Published...
Dec 2, 2019
Marilena Ciciarello, PhD, of University Hospital of Bologna, has been awarded the 2019 ASH Giuseppe Bigi Memorial Award in Hematopoiesis and Stem Cells. This award was established in 2015 to recognize an Italian trainee based at an Italian institution who has the...
Dec 1, 2019
ASH has long recognized the need for comprehensive guidelines and in the past three years has broken ground on developing and/or updating guidelines on several disease types, including venous thromboembolism (VTE), immune thrombocytopenia (ITP), acute myeloid leukemia...
Dec 1, 2019
The field of immunotherapy has generated novel immune-based strategies and improved the utility of existing treatment options for various hematologic diseases. As such, ASH has had an enduring interest in improving immunotherapies for all hematologic diseases. This is...
Nov 27, 2019
The Data Hub, a component of the recently launched ASH Research Collaborative (ASH RC), is a technology platform that facilitates the exchange of information by aggregating research-grade data on hematologic diseases in one place and making it available for inquiry....
Nov 26, 2019
The Minority Graduate Student Abstract Achievement Award is part of the ASH Abstract Achievement Award program. This award program is meant to encourage minority graduate students in the field of hematology and is part of the broader minority recruitment initiative at...
Nov 25, 2019
The National Partner Society Abstract Achievement Awards consist of a $2,000 grant awarded to an international hematologist, who must be a member of the supporting organization and resident of the respective country, to help advance knowledge and inspire continued...
Nov 25, 2019
In 2018 ASH announced an entirely new program for under-represented minority residents, the ASH Minority Resident Hematology Award Program (MRHAP), the goal of which is to provide support for under-represented minority residents to conduct hematology-focused research...
Nov 25, 2019
Since 2004, the ASH Minority Medical Student Award Program (MMSAP) has provided under-represented minority medical students with an opportunity to engage in an eight-to-12-week hematology-related research project under the guidance of an ASH member. In 2016 the...
Nov 25, 2019
In an effort to raise awareness of sickle cell disease (SCD) globally by partnering with international organizations to expand SCD-focused education, ASH is exploring the development of a Consortium of African countries to address newborn screening for SCD. The...
Nov 25, 2019
The Special-Interest Session on Sickle Cell Disease Centers comes about in response to the positive effect that specialized clinical centers have had on increasing access to care for hematologic and nonhematologic diseases alike, including for adults with sickle cell...
Nov 25, 2019
Each year, the ASH annual meeting provides hematology trainees with a variety of high-quality educational, career-development, and networking opportunities. To help trainees make the most of their meeting experience, a number of activities and services have been...
Nov 25, 2019
The International Paroxysmal Nocturnal Hemoglobinuria Interest Group (IPIG) is dedicated to enhancing and expanding professional knowledge about paroxysmal nocturnal hemoglobinuria (PNH) and related disorders in order to improve patient treatment and care. ASH and...
Nov 25, 2019
Hearing the words “How I Treat” might stir up a diverse array of concepts for hematologists. It can refer to both the popular compendium series of Blood articles as well as the format of talks given at the ASH Meeting on Hematologic Malignancies, but it is always...
Nov 25, 2019
Griffin Rodgers, MD, of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is awarded the 2019 ASH Award for Leadership in Promoting Diversity. Dr. Rodgers earned the prestigious recognition for his ongoing work on behalf of under-represented...
